\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\ tm\\ 102\\ p\\ 105\\ bp\\ 120\\/80\\ rr\\ 22\\ spo2\\ 92\\%ra\ \(0\)\
\-\ decreased\\/absent\\ breath\\ sounds\\ lll\\,\\ diffuse\\ crackles\\ and\\ wheezes\\ in\\ lul\ \(0\)\
\-\ \\\\wbc\\ 17\\,000\\\ \(0\)\
\-\ dropping\\ hgb\\ 8\\.2\\ \\(at\\ 0500\\)\\,\\ 7\\.3\\ \\(at\\ 1000\\)\\,\\ 6\\.9\\ \\(at\\ 1500\\)\\platelets\\ 1\\,200\\,000\ \(0\)\
\-\ partial\\ decortication\\ of\\ pleura\ \(0\)\
\-\ partial\\ wedge\\ resection\ \(1\)\
\-\ three\\ tube\\ thoracostomy\ \(0\)\
\-\ picc\\ placement\\ with\\ 6\\ week\\ course\\ of\\ iv\\ vancomycin\ \(0\)\
\-\ cxr\\ findings\\:\ \(0\)\
\-\ airspace\\ disease\\ with\\ possible\\ cavitation\\ in\\ the\\ lingula\\ and\\ left\\ lower\\ lobe\\ along\\ with\\ partially\\ loculated\\ left\\ effusion\\.\\ \\ the\\ mostlikely\\ etiology\\ is\\ infection\\,\\ however\\,\\ other\\ etiologies\\ would\\ include\\ hemorrhage\\.\\ \\ recommend\\ further\\ evaluation\\ with\\ chest\\ ct\\.\\ \ \(0\)\
\-\ chest\\ ct\\ findings\\:\\ \ \(0\)\
\-\ 1\\.\\ \\ large\\,\\ multiloculated\\ pleural\\ fluid\\ collection\\ in\\ the\\ left\\ hemithorax\\ as\\ \\ described\\.\\ \\ slightly\\ more\\ complex\\ regions\\ are\\ present\\ inferiorly\\.\\ \\ \\ \ \(0\)\
\-\ 2\\.\\ \\ streaky\\ air\\ space\\ opacities\\ in\\ the\\ lingula\\ and\\ left\\ lower\\ lobe\\ which\\ may\\ represent\\ superimposed\\ or\\ resolving\\ infection\\ with\\ atelectasis\\.\\ \\ \\ \ \(0\)\
\-\ 3\\.\\ \\ mediastinal\\ and\\ left\\ hilar\\ lymphadenopathy\\ which\\ is\\ most\\ likely\\ reactive\\.this\\ constellation\\ of\\ findings\\ is\\ most\\ likely\\ secondary\\ to\\ bacterial\\ pneumonia\\.\\ \\ although\\ less\\ likely\\ other\\ considerations\\ would\\ include\\ mycobacterial\\ infection\\ such\\ as\\ tb\\.\ \(0\)\
\-\ mrsa\\ pneumonia\\ complicated\\ by\\ empyema\ \(0\)\
\-\ complicated\\ pneumonia\ \(0\)\
\-\ hemorrhage\ \(627\)\
\-\ tb\ \(176\)\
\-\ aids\\ related\\ pulmonary\\ infection\ \(0\)\
\-\ effusion\ \(565\)\
\-\ 45\\ yo\\ female\\ ed\\ nurse\\ at\\ large\\ inner\\ city\\ hospital\\ diagnosed\\ and\\ treated\\ 19\\ days\\ with\\ levaquin\\ for\\ pneumonia\\.\ \(0\)\
\-\ despite\\ antibiotic\\ therapy\\ had\\ persistence\\ of\\ symptoms\\ and\\ presented\\ again\\ to\\ outside\\ hospital\\ with\\ fevers\\ to\\ 103\\,\\ productive\\ cough\\,\\ sob\\,\\ rigors\\ and\\ pleurisy\\.\\ cxr\\ at\\ outside\\ hospital\\ showed\\ worsened\\ findings\\ when\\ compared\\ to\\ earlier\\ cxr\\ and\\ transferred\\ to\\ larger\\ hospital\\ for\\ treatment\\.\ \(0\)\
\-\ 3\\ stages\\ of\\ empyema\\ formation\\ on\\ radiographic\\ studies\\.\\ \ \(1\)\
\-\ stage\\ 1\\:\\ exudative\\ pleural\\ effusion\\ with\\ more\\ than\\ 15\\,000\\ wbc\\/microliter\\.\\ easily\\ drained\ \(0\)\
\-\ stage\\ 2\\:\\ fibrinopurulent\\ stage\\ with\\ formed\\ adhesions\\.\\ decortication\\ may\\ be\\ necessary\\ for\\ treatment\ \(0\)\
\-\ stage\\ 3\\:\\ organizing\\ stage\\ with\\ development\\ of\\ thick\\ pleural\\ peel\\.\\ decortication\\ necessary\\ for\\ treatment\\.\\ \ \(0\)\
\-\ split\\ pleural\\ sign\\:\\ seen\\ in\\ fibrinopurulent\\ and\\ organizing\\ stages\\.\\ \\ requires\\ contrast\\ ct\\ to\\ enhance\\ pleural\\ linings\\ to\\ show\\ separation\\ of\\ the\\ two\\ pleura\\ by\\ the\\ empyema\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ decortication\\:\\ 0\\.06484795071679318\ \(0\)\
\-\ stage\\:\\ 0\\.05105090236594323\ \(0\)\
\-\ pleural\\:\\ 0\\.0464754929786176\ \(0\)\
\-\ fibrinopurulent\\:\\ 0\\.045503480355218784\ \(0\)\
\-\ empyema\\:\\ 0\\.04373613875060734\ \(0\)\
\-\ pneumonia\\:\\ 0\\.03957775568883484\ \(0\)\
\-\ organizing\\:\\ 0\\.037077276451710245\ \(0\)\
\-\ hospital\\:\\ 0\\.036045898767149843\ \(0\)\
\-\ lingula\\:\\ 0\\.03385394790883315\ \(0\)\
\-\ cxr\\:\\ 0\\.030302792194328382\ \(0\)\
\-\ pleura\\:\\ 0\\.0288625029570692\ \(0\)\
\-\ stages\\:\\ 0\\.028720666497773453\ \(0\)\
\-\ infection\\:\\ 0\\.027832118477006243\ \(0\)\
\-\ effusion\\:\\ 0\\.027287175800045388\ \(0\)\
\-\ complicated\\:\\ 0\\.02483748901564491\ \(0\)\
\-\ 120\\/80\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ decreased\\/absent\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ 0500\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ 1\\,200\\,000\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ mostlikely\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ reactive\\.this\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ levaquin\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ wbc\\/microliter\\:\\ 0\\.024693328918673665\ \(0\)\
\-\ tb\\:\\ 0\\.02305343449957469\ \(0\)\
\-\ pleurisy\\:\\ 0\\.022751740177609392\ \(0\)\
\-\ peel\\:\\ 0\\.022751740177609392\ \(0\)\
\-\ linings\\:\\ 0\\.022751740177609392\ \(0\)\
\-\ dropping\\:\\ 0\\.021615983572264394\ \(0\)\
\-\ city\\:\\ 0\\.021615983572264394\ \(0\)\
\-\ 15\\,000\\:\\ 0\\.021615983572264394\ \(0\)\
\-\ necessary\\:\\ 0\\.021204932787529763\ \(0\)\
\-\ 8\\.2\\:\\ 0\\.02081015143654512\ \(0\)\
\-\ findings\\:\\ 0\\.02037912533097994\ \(0\)\
\-\ likely\\:\\ 0\\.02025453752887106\ \(0\)\
\-\ rigors\\:\\ 0\\.020185099472079547\ \(0\)\
\-\ exudative\\:\\ 0\\.020185099472079547\ \(0\)\
\-\ outside\\:\\ 0\\.02008072721071099\ \(0\)\
\-\ 6\\.9\\:\\ 0\\.01967439483120012\ \(0\)\
\-\ 1500\\:\\ 0\\.01967439483120012\ \(0\)\
\-\ streaky\\:\\ 0\\.01967439483120012\ \(0\)\
\-\ nurse\\:\\ 0\\.01967439483120012\ \(0\)\
\-\ 17\\,000\\:\\ 0\\.019242600209835252\ \(0\)\
\-\ partial\\:\\ 0\\.019144849985707257\ \(0\)\
\-\ \\:\\:\\ 0\\.01899621539480109\ \(0\)\
\-\ 7\\.3\\:\\ 0\\.018243510731015274\ \(0\)\
\-\ thoracostomy\\:\\ 0\\.017732806090135847\ \(0\)\
\-\ lul\\:\\ 0\\.017508596824943868\ \(0\)\
\-\ cavitation\\:\\ 0\\.017508596824943868\ \(0\)\
\-\ split\\:\\ 0\\.017508596824943868\ \(0\)\
\-\ 1000\\:\\ 0\\.017107754125670276\ \(0\)\
\-\ would\\:\\ 0\\.01703622901076801\ \(0\)\
\-\ lll\\:\\ 0\\.016926973954416575\ \(0\)\
\-\ mrsa\\:\\ 0\\.016926973954416575\ \(0\)\
\-\ 92\\:\\ 0\\.016757157086583423\ \(0\)\
\-\ 103\\:\\ 0\\.016757157086583423\ \(0\)\
\-\ 102\\:\\ 0\\.016597049484790852\ \(0\)\
\-\ picc\\:\\ 0\\.016597049484790852\ \(0\)\
\-\ mycobacterial\\:\\ 0\\.016597049484790852\ \(0\)\
\-\ spo2\\:\\ 0\\.016445600685714448\ \(0\)\
\-\ vancomycin\\:\\ 0\\.016445600685714448\ \(0\)\
\-\ 105\\:\\ 0\\.016301921989951\ \(0\)\
\-\ at\\:\\ 0\\.016215170207725952\ \(0\)\
\-\ multiloculated\\:\\ 0\\.01616525486342598\ \(0\)\
\-\ tm\\:\\ 0\\.016034946696381464\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.015934210555608043\ \(0\)\
\-\ recommend\\:\\ 0\\.015910431955286693\ \(0\)\
\-\ persistence\\:\\ 0\\.015910431955286693\ \(0\)\
\-\ loculated\\:\\ 0\\.015676870025485425\ \(0\)\
\-\ platelets\\:\\ 0\\.015567008083879596\ \(0\)\
\-\ constellation\\:\\ 0\\.015461292879445853\ \(0\)\
\-\ drained\\:\\ 0\\.015461292879445853\ \(0\)\
\-\ superimposed\\:\\ 0\\.015359422727706707\ \(0\)\
\-\ productive\\:\\ 0\\.015359422727706707\ \(0\)\
\-\ wedge\\:\\ 0\\.015261127714229758\ \(0\)\
\-\ resolving\\:\\ 0\\.014985385213352301\ \(0\)\
\-\ aids\\:\\ 0\\.014985385213352301\ \(0\)\
\-\ formed\\:\\ 0\\.014815568345519151\ \(0\)\
\-\ adhesions\\:\\ 0\\.014734370763241134\ \(0\)\
\-\ treatment\\:\\ 0\\.014534596299167117\ \(0\)\
\-\ wheezes\\:\\ 0\\.0144312514785346\ \(0\)\
\-\ airspace\\:\\ 0\\.0144312514785346\ \(0\)\
\-\ sob\\:\\ 0\\.013968843214222417\ \(0\)\
\-\ crackles\\:\\ 0\\.013908601743015237\ \(0\)\
\-\ separation\\:\\ 0\\.013908601743015237\ \(0\)\
\-\ considerations\\:\\ 0\\.013791871500996838\ \(0\)\
\-\ hemithorax\\:\\ 0\\.01351970413838158\ \(0\)\
\-\ include\\:\\ 0\\.013429431305491802\ \(0\)\
\-\ left\\:\\ 0\\.013390830101861552\ \(0\)\
\-\ hgb\\:\\ 0\\.013319538973165488\ \(0\)\
\-\ etiologies\\:\\ 0\\.013271655406332713\ \(0\)\
\-\ easily\\:\\ 0\\.01322457664354173\ \(0\)\
\-\ worsened\\:\\ 0\\.013178276077852064\ \(0\)\
\-\ ra\\:\\ 0\\.01308790951701671\ \(0\)\
\-\ lobe\\:\\ 0\\.01288137449817106\ \(0\)\
\-\ inner\\:\\ 0\\.012873979604454877\ \(0\)\
\-\ transferred\\:\\ 0\\.012873979604454877\ \(0\)\
\-\ requires\\:\\ 0\\.012713872002662305\ \(0\)\
\-\ inferiorly\\:\\ 0\\.012562423203585903\ \(0\)\
\-\ thick\\:\\ 0\\.012562423203585903\ \(0\)\
\-\ opacities\\:\\ 0\\.012489662737470326\ \(0\)\
\-\ p\\:\\ 0\\.012282077381297435\ \(0\)\
\-\ bacterial\\:\\ 0\\.012248927639989304\ \(0\)\
\-\ antibiotic\\:\\ 0\\.012248927639989304\ \(0\)\
\-\ rr\\:\\ 0\\.01221616562384591\ \(0\)\
\-\ hilar\\:\\ 0\\.012027254473158146\ \(0\)\
\-\ more\\:\\ 0\\.011972976522757235\ \(0\)\
\-\ earlier\\:\\ 0\\.011821844744627195\ \(0\)\
\-\ enhance\\:\\ 0\\.011578115397317306\ \(0\)\
\-\ larger\\:\\ 0\\.011526717249787344\ \(0\)\
\-\ atelectasis\\:\\ 0\\.011501367570459844\ \(0\)\
\-\ again\\:\\ 0\\.011501367570459844\ \(0\)\
\-\ chest\\:\\ 0\\.011455064426092542\ \(0\)\
\-\ vitals\\:\\ 0\\.011451346233204924\ \(0\)\
\-\ fevers\\:\\ 0\\.011377950232101215\ \(0\)\
\-\ 3\\:\\ 0\\.011209946928327953\ \(0\)\
\-\ despite\\:\\ 0\\.011124177415988536\ \(0\)\
\-\ 45\\:\\ 0\\.011058778637285478\ \(0\)\
\-\ most\\:\\ 0\\.011052297712762331\ \(0\)\
\-\ 19\\:\\ 0\\.011037314007746069\ \(0\)\
\-\ other\\:\\ 0\\.011034389628585146\ \(0\)\
\-\ partially\\:\\ 0\\.010953063432851733\ \(0\)\
\-\ regions\\:\\ 0\\.010953063432851733\ \(0\)\
\-\ lower\\:\\ 0\\.01076673428215049\ \(0\)\
\-\ 22\\:\\ 0\\.01067667259949871\ \(0\)\
\-\ represent\\:\\ 0\\.010512390450811012\ \(0\)\
\-\ may\\:\\ 0\\.010500439041446073\ \(0\)\
\-\ large\\:\\ 0\\.01046802482818532\ \(0\)\
\-\ development\\:\\ 0\\.010425121073276571\ \(0\)\
\-\ bp\\:\\ 0\\.010390960644442346\ \(0\)\
\-\ described\\:\\ 0\\.010194310059923443\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.010178529057911521\ \(0\)\
\-\ mediastinal\\:\\ 0\\.010162836465338216\ \(0\)\
\-\ etiology\\:\\ 0\\.010131712584595722\ \(0\)\
\-\ collection\\:\\ 0\\.010131712584595722\ \(0\)\
\-\ compared\\:\\ 0\\.010131712584595722\ \(0\)\
\-\ ed\\:\\ 0\\.010116279375041184\ \(0\)\
\-\ tube\\:\\ 0\\.010085665732093872\ \(0\)\
\-\ ct\\:\\ 0\\.01004456851589952\ \(0\)\
\-\ related\\:\\ 0\\.009880256003562921\ \(0\)\
\-\ formation\\:\\ 0\\.009880256003562921\ \(0\)\
\-\ placement\\:\\ 0\\.009715436675767589\ \(0\)\
\-\ slightly\\:\\ 0\\.009675703804641661\ \(0\)\
\-\ complex\\:\\ 0\\.009585128508723072\ \(0\)\
\-\ sounds\\:\\ 0\\.00954718950281899\ \(0\)\
\-\ cough\\:\\ 0\\.009171582293580035\ \(0\)\
\-\ radiographic\\:\\ 0\\.009085054318735948\ \(0\)\
\-\ course\\:\\ 0\\.00903230096206062\ \(0\)\
\-\ breath\\:\\ 0\\.008949909126748874\ \(0\)\
\-\ studies\\:\\ 0\\.008939778481174117\ \(0\)\
\-\ which\\:\\ 0\\.008936384242255175\ \(0\)\
\-\ diagnosed\\:\\ 0\\.008801667105868364\ \(0\)\
\-\ iv\\:\\ 0\\.008735083858434436\ \(0\)\
\-\ wbc\\:\\ 0\\.008725699861556897\ \(0\)\
\-\ to\\:\\ 0\\.00837388447927424\ \(0\)\
\-\ sign\\:\\ 0\\.00829256723183213\ \(0\)\
\-\ 3\\.\\:\\ 0\\.008190123843531448\ \(0\)\
\-\ for\\:\\ 0\\.008169278976388965\ \(0\)\
\-\ week\\:\\ 0\\.008128894729210722\ \(0\)\
\-\ less\\:\\ 0\\.008106274521912276\ \(0\)\
\-\ air\\:\\ 0\\.008098774864291221\ \(0\)\
\-\ although\\:\\ 0\\.008083835519822419\ \(0\)\
\-\ three\\:\\ 0\\.008068975429543166\ \(0\)\
\-\ possible\\:\\ 0\\.008061574842812527\ \(0\)\
\-\ by\\:\\ 0\\.007971265564397057\ \(0\)\
\-\ space\\:\\ 0\\.007917526630466763\ \(0\)\
\-\ along\\:\\ 0\\.007910515061228337\ \(0\)\
\-\ showed\\:\\ 0\\.007848188425556573\ \(0\)\
\-\ further\\:\\ 0\\.007611888352381676\ \(0\)\
\-\ 2\\.\\:\\ 0\\.007611888352381676\ \(0\)\
\-\ such\\:\\ 0\\.0074827249015149925\ \(0\)\
\-\ 1\\.\\:\\ 0\\.0074767203537747925\ \(0\)\
\-\ resection\\:\\ 0\\.007464749735350753\ \(0\)\
\-\ show\\:\\ 0\\.0073477757268673\ \(0\)\
\-\ days\\:\\ 0\\.00733634256630806\ \(0\)\
\-\ diffuse\\:\\ 0\\.007246519384804803\ \(0\)\
\-\ as\\:\\ 0\\.007241330565233209\ \(0\)\
\-\ yo\\:\\ 0\\.007202665331380286\ \(0\)\
\-\ treated\\:\\ 0\\.007164848280346945\ \(0\)\
\-\ 6\\:\\ 0\\.007148795970237743\ \(0\)\
\-\ pulmonary\\:\\ 0\\.006993138123865724\ \(0\)\
\-\ evaluation\\:\\ 0\\.006953049848254364\ \(0\)\
\-\ when\\:\\ 0\\.006855269573154078\ \(0\)\
\-\ two\\:\\ 0\\.006855269573154078\ \(0\)\
\-\ \\,\\:\\ 0\\.006824623500435816\ \(0\)\
\-\ fluid\\:\\ 0\\.006802910657153651\ \(0\)\
\-\ secondary\\:\\ 0\\.006691960690500862\ \(0\)\
\-\ however\\:\\ 0\\.006664896514277509\ \(0\)\
\-\ presented\\:\\ 0\\.006524811302583779\ \(0\)\
\-\ therapy\\:\\ 0\\.006399554051094154\ \(0\)\
\-\ than\\:\\ 0\\.00627184553198396\ \(0\)\
\-\ \\(\\:\\ 0\\.006070266607091265\ \(0\)\
\-\ \\)\\:\\ 0\\.005996115059775673\ \(0\)\
\-\ symptoms\\:\\ 0\\.005965427106157253\ \(0\)\
\-\ in\\:\\ 0\\.0059019219907598735\ \(0\)\
\-\ 1\\:\\ 0\\.005695592067114025\ \(0\)\
\-\ \\%\\:\\ 0\\.005583532306291338\ \(0\)\
\-\ present\\:\\ 0\\.005406186985803027\ \(0\)\
\-\ contrast\\:\\ 0\\.005357915089097774\ \(0\)\
\-\ had\\:\\ 0\\.0051648454320468015\ \(0\)\
\-\ 2\\:\\ 0\\.005154354331962314\ \(0\)\
\-\ female\\:\\ 0\\.004920897118901495\ \(0\)\
\-\ seen\\:\\ 0\\.004730049341926303\ \(0\)\
\-\ is\\:\\ 0\\.004725132591468282\ \(0\)\
\-\ and\\:\\ 0\\.0045380421613164315\ \(0\)\
\-\ disease\\:\\ 0\\.003912430087438947\ \(0\)\
\-\ be\\:\\ 0\\.003691195303484395\ \(0\)\
\-\ with\\:\\ 0\\.0032774279016775836\ \(0\)\
\-\ are\\:\\ 0\\.003262952023892442\ \(0\)\
\-\ or\\:\\ 0\\.0028053858514389567\ \(0\)\
\-\ the\\:\\ 0\\.002323517389976904\ \(0\)\
\-\ of\\:\\ 0\\.0022843882509409495\ \(0\)\
\-\ on\\:\\ 0\\.0020277059169899947\ \(0\)\
\-\ \\.\\:\\ 0\\.001789892576336787\ \(0\)\
